J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like ...
GlobalData on MSN
J&J starts SKYWARD study of carotid IVL system
The SKYWARD programme includes two planned prospective, multi-centre, single-arm IDE studies.
SANTA CLARA, Calif. and SINGAPORE, May 23, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...
FREMONT, Calif., Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced clearance from the U.S. Food and Drug Administration (FDA) of the Lithoplasty ® ...
FREMONT, Calif. & WASHINGTON--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today reported positive safety, performance and intravascular imaging ...
Evidence on the safety of extracorporeal shockwave therapy for calcific tendinopathy in the shoulder shows no major safety concerns in the short term. Evidence on efficacy is inadequate. Therefore, ...
Shockwave Medical, Inc. SWAV, along with Genesis MedTech Group, received approval from China’s National Medical Products Administration for Intravascular Lithotripsy (“IVL”). The clearance paves the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results